Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sphenopalatine Ganglion Acupuncture for Allergic Rhinitis
NCT07784491Not yet recruiting
- Sponsor
- Zhongshan Torch Hi-tech Industrial Development Zone People's Hospital
- Start
- Aug 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Randomised, open-label trial in allergic rhinitis (AR) (3 arms), sponsored by Zhongshan Torch Hi-tech Industrial Development Zone People's Hospital. Primary endpoint: Total Nasal Symptom Score at Month 6. Planned start Aug 2026; status: not yet recruiting.
02
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT07784491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07784491.